Therefore, plasma betatrophin may indirectly reflect the progression of NAFLD, namely NASH incidence, which was consistent with the findings from the study of Arias-Loste et al [23]. Here, ANGPTL8 is linked to metabolic dysfunction-associated steatotic liver disease.